Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

Brilacidin ph2b ABSSSI is listed on clinicaltrials.gov and can be found here.

https://clinicaltrials.gov/ct2/results?term=brilacidin%2C+pmx30063

https://clinicaltrials.gov/ct2/show/NCT02052388?term=brilacidin%2C+pmx30063&rank=2




April 27, 2015
Copenhagen, Denmark
25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2015): “A Randomized, Double-Blind Study Comparing Single-Dose and Short-Course Brilacidin...

https://static1.squarespace.com/static/5715352e20c647639137f992/t/583f8286d2b85731b8713a36/1480557192947/A-Randomized-Double-Blind-Study-Comparing-Single-Dose-and-Short-Course-Brilacidin-to-Daptomycin-in-the-Treatment-of-Acute-Bacterial-Skin-Skin-Structure-Infections-ABSSSI1.pdf


https://aac.asm.org/content/aac/early/2014/06/11/AAC.02955-14.full.pdf







In Reply to 'kfcyahoo'
Empirics1,,

You state, in part, "Why are you writing off the successful 2b for B for ABSSSI uses, ....

Why is the phase 2b trial you noted not acknowledged by clinicaltrials.gov? Where was the trial administered, and what agency knows the specifics, and who, other than ipix, can corroborate company statements of success?